Article Versions Notes

Ung J, Tan S-F, Fox TE, Shaw JJP, Taori M, Horton BJ, Golla U, Sharma A, Szulc ZM, Wang H-G, et al. Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia. Cancers. 2023; 15(24):5866. https://doi.org/10.3390/cancers15245866

Ung, Johnson, Su-Fern Tan, Todd E. Fox, Jeremy J. P. Shaw, Maansi Taori, Bethany J. Horton, Upendarrao Golla, Arati Sharma, Zdzislaw M. Szulc, Hong-Gang Wang, and et al. 2023. "Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia" Cancers 15, no. 24: 5866. https://doi.org/10.3390/cancers15245866

Ung, J., Tan, S.-F., Fox, T. E., Shaw, J. J. P., Taori, M., Horton, B. J., Golla, U., Sharma, A., Szulc, Z. M., Wang, H.-G., Chalfant, C. E., Cabot, M. C., Claxton, D. F., Loughran, T. P., Jr., & Feith, D. J. (2023). Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia. Cancers, 15(24), 5866. https://doi.org/10.3390/cancers15245866